2.41 +0.00 (0.00%)
PARD
| Trade PARD now with |
|
Stock Details
Last Trade:2.41 Change:+0.00 (0.00%) Prev Close:2.41 Open: 29.35 Days Range:2.41 – 2.41 52 Week Range: 0.10 - 3.20 Volume:5060 P/E: N/AEPS:-12.00
View AllRecent Alerts 02/07/12
Recent Alert on 01/03/12 at 8:21am
Poniard (PARD) to Delist from Nasdaq; CEO Ronald Martell Shifts to Chairman Role
Poniard (PARD) to Delist from Nasdaq; CEO Ronald Martell Shifts to Chairman Role
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) reports that the Nasdaq Hearings Panel has determined to delist the Company's common stock from the Nasdaq Stock Market and suspend trading in the shares effective at the open of business today, January... Read More
Recent Alert on 01/03/12 at 8:21am
Poniard (PARD) to Delist from Nasdaq; CEO Ronald Martell Shifts to Chairman Role
Poniard (PARD) to Delist from Nasdaq; CEO Ronald Martell Shifts to Chairman Role
Recent Alert on 12/22/11 at 8:08am
Poniard (PARD) Announces Termination of Merger with Allozyne; Board 'Actively Exploring Alternatives'
Poniard (PARD) Announces Termination of Merger with Allozyne; Board 'Actively Exploring Alternatives'
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 03/06/11 at 8:43am
China Biotech in Review: Thermo Fisher Scientific Displays Increased Commitment
China Biotech in Review: Thermo Fisher Scientific Displays Increased Commitment
Blog Posts on 11/09/10 at 7:22pm
Poniard Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript
Poniard Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript